Atossa Therapeutics
ATOS
#10732
Rank
NZ$39.39 M
Marketcap
NZ$3.95
Share price
3.76%
Change (1 day)
164.43%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -NZ$65.51 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$62.11 Million a decrease over its 2024 earnings that were of -NZ$45.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$65.51 Million5.47%
2025 -NZ$62.11 Million36.33%
2024 -NZ$45.56 Million-15.25%
2023 -NZ$53.76 Million11.62%
2022 -NZ$48.16 Million30.84%
2021 -NZ$36.81 Million15.58%
2020 -NZ$31.85 Million3.41%
2019 -NZ$30.8 Million51.16%
2018 -NZ$20.38 Million40.41%
2017 -NZ$14.51 Million27.54%
2016 -NZ$11.38 Million-47.49%
2015 -NZ$21.67 Million-17.25%
2014 -NZ$26.19 Million35.91%
2013 -NZ$19.27 Million112.3%
2012 -NZ$9.08 Million46.53%
2011 -NZ$6.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.43 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.66 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.60 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$74.44 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$58.83 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$14.01 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA